Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cel crawled time : 08:00 save search
Non-small Cell Lung Cancer Drugs Market to Grow by USD 30.23 billion| Increasing Prevalence and Incidence of Non-small Cell Lung Cancer to Boost Market Growth | Technavio
Published: 2022-03-08 (Crawled : 08:00) - prnewswire.com
AZNCF | News | $135.35 400
|
Health Technology
|
| O: -2.09%
H: 5.03%
C: 0.85%
ALPMY | News | $9.47 400K
|
Manufacturing
|
| O: 1.01%
H: 0.81%
C: -0.06%
NVS | News | $98.67 0.33% 260K
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
ABBV | News | $166.41 -0.83% 860K
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
SNY | News | $49.085 5.31% 1.2M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
AZN | News | $75.37 5.86% 2.7M
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: 0.0%
AMGN | News | $271.635 -0.5% 120K
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
drug cel lung cancer cancer drug cancer growth
Celyad Oncology Announces Clinical Hold of CYAD-101-002 Phase 1b Trial
Published: 2022-03-02 (Crawled : 08:00) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: -8.79%
cyad-101 clinical hold phase 1b trial cel phase 1 phase 2b
NXP Powers Compal’s New Integrated Small Cell Solution to Address 5G Network Densification
Published: 2022-03-01 (Crawled : 08:00) - globenewswire.com
NXPI | $237.81 1.18% 180K
|
Electronic Technology
|
| O: -1.43%
H: 0.0%
C: 0.0%
cel work 5g
Celyad Oncology Announces Voluntary Pause of CYAD-101-002 Phase 1b Trial
Published: 2022-02-28 (Crawled : 08:00) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -10.87%
H: 0.7%
C: -6.97%
cyad-101 phase 1b trial cel phase 1 phase 2b
ArcelorMittal announces that its Significant Shareholder has decided not to further participate in its $1 billion share buyback program
Published: 2022-02-25 (Crawled : 08:00) - globenewswire.com
AMSYF | News | $26.89 -10.71% 200
|
Non-Energy Minerals
|
| O: 10.72%
H: 1.89%
C: 1.89%
MT | News | $24.835 -1.45% 150K
|
Non-Energy Minerals
|
| O: 10.38%
H: 0.0%
C: 0.0%
ces program cel
Regulatory T-cells (Tregs) Therapies Market - Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot
Published: 2022-02-16 (Crawled : 08:00) - prnewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: -0.52%
H: 1.83%
C: 1.24%
NKTR | News | $1.355 -1.81% 68K
|
Health Technology
|
| O: -0.27%
H: 1.26%
C: 0.36%
trial cel t-cell therapy
Data Center Accelerators Market revenue to cross USD 25 Bn by 2028: Global Market Insights Inc.
Published: 2022-02-15 (Crawled : 08:00) - prnewswire.com
WDC 4 | $68.58 -1.4% 2M
|
Electronic Technology
|
| O: 0.61%
H: 5.18%
C: 5.06%
QCOM | $162.87 -0.46% 660K
|
Electronic Technology
|
| O: 2.34%
H: 2.93%
C: 2.37%
NVDA | News | $810.585 1.73% 9.9M
|
Electronic Technology
|
| O: 2.81%
H: 6.4%
C: 6.2%
MU M | $110.91 -0.78% 3.5M
|
Electronic Technology
|
| O: 1.28%
H: 6.03%
C: 5.48%
INTC | $34.645 0.42% 4.9M
|
Electronic Technology
|
| O: 0.25%
H: 1.59%
C: 1.55%
GOOGL | News 4 | $152.57 -4.12% 9.3M
|
Technology Services
|
| O: 1.51%
H: 0.39%
C: -0.7%
GOOG | News 4 | $154.495 -4.1% 6.4M
|
Technology Services
|
| O: 1.6%
H: 0.31%
C: -0.76%
AMD | $151.25 -0.32% 7.2M
|
Electronic Technology
|
| O: 2.56%
H: 4.0%
C: 3.65%
cel market
NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR(TM) in Head and Neck Squamous Cell Carcinoma
Published: 2022-02-11 (Crawled : 08:00) - biospace.com/
NEO | $13.58 -3.21% 47K
|
Health Services
|
| O: -1.5%
H: 0.0%
C: 0.0%
genomics genomic cel positive results positive results head and neck cell carcinoma
Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR™ in Head and Neck Squamous Cell Carcinoma
Published: 2022-02-11 (Crawled : 08:00) - biospace.com/
NEO | $13.58 -3.21% 47K
|
Health Services
|
| O: -1.5%
H: 0.0%
C: 0.0%
cel positive results positive results head and neck cell carcinoma
Core One Labs’ Akome Biotech Signs Research Agreement with University of Barcelona, Faculty of Pharmacy and Food Sciences
Published: 2022-01-26 (Crawled : 08:00) - globenewswire.com
CLABF | $0.1496 5.2% 0
|
Process Industries
|
| O: 0.65%
H: 4.55%
C: 2.73%
research cel food one biotech iot
Personal Luxury Goods Market size to grow by USD 33.53 billion and Accelerate at a CAGR of over 2.59%|Technavio
Published: 2022-01-24 (Crawled : 08:00) - prnewswire.com
PPRUF | News | $345.01 1.6K
|
Consumer Non-Durables
|
| O: -3.88%
H: 1.61%
C: 0.81%
LVMHF | $859.75 380
|
Consumer Non-Durables
|
| O: -2.19%
H: 0.67%
C: -0.03%
PPRUY | News | $34.9595 390K
|
Manufacturing
|
| O: -2.32%
H: 1.54%
C: 1.28%
LVMUY | $171.62 190K
|
Retail Trade
|
| O: -2.84%
H: 0.6%
C: 0.6%
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -16.2%
H: 0.72%
C: -4.06%
COTY | $11.49 -1.8% 560K
|
Consumer Non-Durables
|
| O: -7.39%
H: 4.3%
C: 3.56%
cel
Eastman to invest up to $1 billion to accelerate circular economy through building world's largest molecular plastics recycling facility in France
Published: 2022-01-17 (Crawled : 08:00) - prnewswire.com
EMN | $95.39 -1.01% 88K
|
Process Industries
| Email alert
Add to watchlist
cel molecular
American CryoStem Announces Completion of Patient Recruitment for its Post-Concussion Syndrome (PCS) ATCELL(TM) Phase I Clinical Trial
Published: 2021-12-22 (Crawled : 08:00) - biospace.com/
CRYO | $0.0001 0.0% 19K
|
Information
|
| O: 2.3%
H: 8.55%
C: 2.31%
trial cel cryo syndros
BMO Financial Group accelerates North American growth with strategic acquisition of Bank of the West
Published: 2021-12-20 (Crawled : 08:00) - prnewswire.com
BNPQF | News | $70.45 1.8K
|
Finance
|
| O: 0.92%
H: 4.28%
C: 4.28%
BNPQY | News | $36.5 94K
|
Finance and Insurance
|
| O: 1.94%
H: 0.5%
C: 0.31%
MS | News 0 d | $92.17 -1.79% 530K
|
Finance
|
| O: -3.85%
H: 0.29%
C: -0.25%
BMO | $91.82 -1.1% 2.8M
|
Finance
|
| O: -2.82%
H: 0.16%
C: -0.77%
acquisition cel growth group
Gainers vs Losers
| 44% | 56% |
Top 10 Gainers
SGBX | $0.26 80.43% 54M
|
Producer Manufacturing
LICN | $1.0 78.57% 3.3M
|
CSSE 4 | $0.2656 74.39% 9.7M
|
Consumer Services
BRFH 4 | $1.89 71.82% 32M
|
Manufacturing
BOF | $1.95 66.67% 920K
|
MTC | $3.62 61.61% 790K
|
Technology Services
AMST | $3.13 56.5% 500K
|
Technology Services
PCSA | $2.28 40.74% 37M
|
Producer Manufacturing
EVA | $0.626 39.14% 2.3M
|
Process Industries
OPTN | $1.215 31.31% 12M
|
Health Services
Your saved searches
Save your searches and get alerts when important news are released.